Exacerbation Reduction and Improved Quality of Life in Asthma with Extrafine Formulation Single-Inhaler Triple Therapy (efSITT): Six-Month Results of the TriMaximizeStudy

Trinkmann et al.

Download here

TriMaximize Poster ERS 2024 Exacerbation Mini AQLQ

Download here

Improvement in Lung Function after Six Months of Treatment with Extrafine Formulation Single-Inhaler Triple Therapy (efSITT) in Patients with Asthma -TriMaximize Study

Gessner et al.

Download here

TriMaximize Poster ERS 2024 Lung function

Download here

Impact of Extrafine Formulation Single-Inhaler Triple Therapy on Asthma Control and Treatment Adherence after Six Months of Treatment in Patients with Asthma

Greulich et al.

Download here

TriMaximize Poster ERS 2024 ACT-TAI final

Download here